The standard analyst approach of using net price assumptions based on class-level historical rebate rates is insufficient for drugs entering competitive therapeutic classes where PBM negotiating behavior is documented and predictable
If the frequency detected is above 39 Hz (in a mean of 10 measurements), the test is considered normal
Suspecting oxidative stress as a driver of fatigue or aging: Mito Core Panel first to identify which specific pathway (methylation, mitochondrial, inflammation) is most affected
Medical decisions Eligibility determinations are made by licensed clinicians following review of submitted intake information
However, attempts to identify it have failed and there is no obvious candidate in the genome [58, 59]
Employers should also consider the potential impact on related conditions, healthcare utilization, and long-term health outcomes